Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J9317 (Trodelvy) Fee Schedule
Last Verified: October 2026
Healthcare providers use this code to document and receive reimbursement for visits that address moderate-level medical decision-making, often including multiple diagnoses or prescription management.
Injection, sacituzumab govitecan-hziy, 2.5 mg
| Key Fact | Detail |
|---|---|
| Service Type | Chemotherapy Drugs |
| Common Place of Service | None 11 - Office 22 - On Campus Outpatient Hospital |
| Complexity Level | Low |
| Medicaid Fee Schedule | View Medicaid rates for J9317 |
| Medicare Payment Limit | $36.276  |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 55135-0132-01 - TRODELVY (PF,LYOPHILIZED) 180 MG |
National average reimbursement for HCPCS J9317 by major payers:
$36.99
$37.16
$38.35
$36.72
Compare published rates across providers.
Choose a payer to see a sample of rates for HCPCS J9317.
HCPCS J9317
5 of 25 sample ratesHigher to lower in this preview
Ayesha Sheikh
Scott & White Clinic
$68.22Published rateCancer Therapy And Research Center
Amy Halanski Md PC / Austin Pathology Associates / Bexar County Hospital District
$45.36Published rateLaredo Arthritis & Rheumatology Center, PLLC, Laredo Arthritis & Rheumatology Center,PLLC
Laredo Arthritis Rheumatology Center PLLC
$37.56Published rateElizabeth Solow
Abksw Preferred Health Partners PLLC / Action Family Care PLLC / Adam S Miner Md PA
$35.43Published rateLatha Prasannan
Medical Center South Texas Center For Pediatric Care
$30.12Published rate
Get a free rate benchmark for your specialty.
Choose your state and specialty to build a report from payer-published rates.
Use market rates to prepare your payer proposal.
Payer Contract Negotiation
Draft a fee schedule renegotiation letter.
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J9317 vs. Other Chemotherapy Drugs Codes
The HCPCS J9317 code is part of the Chemotherapy Drugs services . It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.
The HCPCS J9317 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.
| Code | Complexity | Description |
|---|---|---|
| 55135-0132-01-NDC | Moderate | TRODELVY (PF,LYOPHILIZED) 180 MG |
| J9316-HCPCS | Low | Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg |
| J9317-HCPCS | Low | Injection, sacituzumab govitecan-hziy, 2.5 mg |
| J9318-HCPCS | Low | Injection, romidepsin, non-lyophilized, 0.1 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J9317. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J9317 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
FREE SAMPLE MARKET COMPARISON
Let's review your payer contracts side-by-side with the market.
Bring your top codes (like HCPCS J9317) and we'll show you how you compare in 15 minutes or less.